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Abstract
Objective: To develop guidance for clinicians participating in the
informed choice process with respect to the donation of human
embryos for research purposes.
Recommendations
1. As indicated in the Canadian Institutes of Health Research
Guidelines and the Assisted Human Reproduction Act, specific
consent from both the gamete and embryo providers is required
before embryos can be used for research purposes. The gamete
donors may be different individuals than the embryo providers
when donated gametes are used to create embryos.
2. The consent process should inform potential donors of the
possible types of (and for final consent, the specific) research
project(s) for which the embryos will be used; the risks involved in

donating embryos to research, such as not having these embryos
available for their reproductive purposes; the fact that the
woman/couple will not benefit personally from donating embryos to
research; the potential for commercial gain by others; the
possibility that they will be contacted in future about the disposition
of the embryos; the fact that confidentiality cannot be absolutely
guaranteed.
3. Designation of cryopreserved embryos no longer be required for
reproductive purposes to be donated to research, donated to
another couple, or discarded should be discussed prior to gamete
retrieval and made at the time of cryopreservation, with the
understanding that in the future, final consent will be requested.
The final decision as to the donation of cryopreserved embryos
research should not be made until after the woman/ couple decide
they no longer require the embryos for their reproductive
purposes. The decision to end cryopreservation should be made
separately from the decision regarding disposition of the embryos.
The woman/couple will have to be re-contacted regarding the final
disposition of their embryos.
4. As a result of lack of scientific data regarding the predictability of
microscopic characterization of embryos and potential for
pregnancy, it is recommended that all women/couples be offered
the opportunity to cryopreserve all embryos not transferred during
the treatment cycle and be informed that a failure to cryopreserve
all embryos may increase the chance of having to undergo an
additional in vitro fertilization cycle to achieve reproductive goals.
5. Research participants should be informed that they may withdraw
their consent at any time before the embryos are thawed for
research purposes, or, in the case of stem cell research, before a
stem cell line is created.
6. Potential donors should be informed that their medical care will not
be affected by their decision regarding embryo donation.
J Obstet Gynaecol Can 2008;30(9):824–829

INTRODUCTION

his SOGC clinical practice guideline is established to
assist clinicians in understanding and complying with
the laws, guidelines, and obligations of best medical practice
regarding the donation of embryos to research. While this
policy statement and the accompanying recommendations
are directed primarily at clinicians, they should guide all parties involved in research using donated human embryos.

T

Key Words: Embryo research, consent, embryo donation

This document reflects emerging clinical and scientific advances on the date issued and is subject to change. The information
should not be construed as dictating an exclusive course of treatment or procedure to be followed. Local institutions can dictate
amendments to these opinions. They should be well documented if modified at the local level. None of these contents may be
reproduced in any form without prior written permission of the SOGC.
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In Canada, research involving human embryos is permitted
in some circumstances and is governed by the Assisted
Human Reproductive Act1 and the Tri-Council Policy
Statement: Ethical Conduct for Research Involving
Humans.2 Guidelines specific to human pluripotent stem
cell research were issued by the CIHR in 2002, and updated
in 2005 and 2006.3
In Canada, embryos may be created only for reproductive
purposes.1 The only embryos available for research in
Canada are those that are no longer required for reproductive purposes, when the gamete and embryo providers have
given written consent to their use. Embryos may also be
used for improving, or providing instruction in, assisted
human reproduction procedures in some circumstances.1
Consistent with the provisions of the AHR Act, the TCPS,
and the CIHR Guidelines, this policy statement is underpinned by five fundamental considerations:
1. Safeguards must be present to ensure that embryos
donated for research are no longer required for
reproductive purposes.
2. A recognition that providing free and informed
consent to the donation of embryos for research is a
multi-staged process that involves all gamete and
embryo donors.
3. A recognition of the importance of
non-commercialization of reproductive materials and
capacities.
4. A recognition that while all persons are affected by
assisted reproductive technologies, women are more
directly and significantly affected than men by their
application, and the health and wellbeing of women
are of paramount concern.
5. A recognition that consent to the use of embryos in
research “means fully informed and freely given
consent” thereby acknowledging that freedom of
consent can be undermined in many ways, including
by financial pressures and uncertainty about the
confidentiality of decisions.

INFORMED CONSENT TO THE
DONATION OF EMBRYOS FOR RESEARCH

Because each egg retrieval cycle involves significant potential harm to women, best practice requires that clinicians
ensure that women not undergo avoidable egg retrieval procedures. These potential harms are related to the medications used in ovarian stimulation4-7 and include ovarian
hyperstimulation syndrome, which can cause severe complications in about 0.05% to 5% of IVF cycles4,8 and, in very
rare cases, can be fatal. Long-term risks of ovarian stimulation are hypothesized9 but remain unproven. Risks are also
associated with oocyte retrieval.10 Given the health risks
involved in menotropin stimulation and oocyte retrieval, all
embryos that are created following ovum retrieval are to be
made available for the reproductive goals of the
woman/couple concerned. It is for the woman/couple to
decide when their reproductive needs have been met.
Therefore, after transfer of one or two fresh embryos to the
woman’s uterus,11 all additional embryos should generally
be frozen for possible use in future cycles, depending upon
the wishes of the woman or couple.12 It is only after it is
confirmed that the woman/couple will have no interest in
using the embryos for future reproductive purposes that it
becomes appropriate to consider use of these embryos in
research projects. The informed consent process must be
designed to clearly and specifically reflect both clinical and
psychosocial concerns.
Who Should Give Consent?

The TCPS,2 CIHR Guidelines,3 and the AHR Act1 all
require specific consent from both the gamete and embryo
providers before embryos can be used for research purposes. The gamete donors may be different individuals than
the embryo providers when donated gametes are used to
create embryos. When embryos are created from gametes
of a third party donor, it may not be possible to ascertain
whether the gamete donor(s) consented to research on
embryos created using their gametes. This may be the case,
for example, in the context of anonymous gamete donation.
Without the consent of the gamete donor(s) these embryos
cannot be donated for use in research.
When Should Consent Be Obtained?
The decision to cryopreserve

ABBREVIATIONS
AHR

Assisted Human Reproduction

CIHR

Canadian Institutes of Health Research

IVF

in vitro fertilization

TCPS

Tri-Council Policy Statement: Ethical Conduct for
Research Involving Humans

The purpose of this policy statement is to provide guidance
for SOGC members who may be in a position to seek
informed consent to the use of embryos in research. It does
not speak directly to policy and practice concerning cryopreservation of embryos. However, as this issue is intimately bound up with the question of embryo donation,
and, in particular, with the donation of fresh embryos, some
discussion of this is necessary.
SEPTEMBER JOGC SEPTEMBRE 2008 l
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Following IVF, women/couples will be provided with
information about the number of embryos that have been
produced and offered the opportunity to cryopreserve
embryos that are not to be transferred in a particular IVF
cycle for transfer in the future.
Decisions about the disposition of embryos that are not
immediately transferred following IVF are made at a time
when women/couples are uncertain about reproductive
outcomes and when they are uncertain about whether those
embryos that have not been transferred will be required in
the future for reproductive purposes.
While some take the view that it is possible to determine the
likelihood that any specific embryo will go on to create a
pregnancy, or will survive the freeze/thaw process, there is
no scientific consensus on this point.12–14 A decision not to
cryopreserve all remaining embryos can be an informed
decision only when women/couples are told that there is no
consensus about how to determine which embryos are suitable for cryopreservation, and that different clinics have different views about whether any specific embryo is suitable
for cryopreservation.12–13 Because of this lack of consensus,
it is recommended that all women/couples be offered the
opportunity to cryopreserve all remaining embryos, and
that clinicians ensure they understand that a failure to
cryopreserve all embryos may increase the chance of having
to undergo an additional IVF cycle in order to achieve
reproductive goals.
Cryopreserved embryo donation

In Canada, the only embryos that can be used for research
are those no longer required for the reproductive needs of
the women/couples for whom they were created through
IVF1; therefore, women/couples should not be asked to
donate embryos to research until they have decided they no
longer require their embryos for reproductive purposes.
However, the AHR Act1 and CIHR Guidelines3 indicate
that the informed consent process for donating embryos no
longer required for reproductive purposes to research
should begin prior to gamete retrieval. The options for disposition of any embryos that are no longer required for
reproductive purposes are to donate the embryos to
another party for reproductive use, to donate them to
research, or to discard them. This initial stage of the
informed consent process registers the preliminary intention of the woman/couple who are informed at that time
that they will be contacted again to make a final decision
about the disposition and use of their embryos.
After completing their families through IVF or abandoning
infertility treatment, women/couples will need to confirm
their original disposition intention before it can be acted
upon. At this stage, it is imperative to ensure that the two
decisions—to end embryo storage and to determine
826
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disposition of embryos—are made separately, because
potential donors may now have come to different views
about donating their excess embryos for use in research.
Further, regarding donation to research, the particular project should be identified prior to consent being given.
Potential donors must, therefore, be asked again whether
they wish to donate their embryos to research when the
embryos are being sought for use in a particular research
project.
Fresh embryo donation

The donation of fresh, rather than cryopreserved, embryos
gives rise to unique issues and concerns, and poses challenges for the process of informed consent. First, in the case
of fresh embryos, donors will not have the ability to reconsider their initial decision about donation at some distance
from the clinical encounter and in circumstances in which
they are informed about the reproductive outcomes of a
specific IVF treatment cycle. It is important that potential
donors understand that once the embryos have been
donated and used in research, there is no possibility of
re-thinking the decision not to cryopreserve the embryos in
question. Second, the time frame in which a decision about
fresh embryo donation needs to be made is significantly
abbreviated and might not provide potential donors with
the time they need to make a thoughtful decision about
donation that reflects their own needs and interests. Third,
potential donors might feel pressured to agree to donate
embryos or might worry that refusing consent will lead to
their ongoing IVF treatment being compromised, even
though the clinicians do not purposefully give this impression.12,15,16 Based on these concerns, clinicians should not
ask their patients to consider donating fresh embryos to
research unless and until the woman/couple have decided
that they do not wish to cryopreserve their embryos.
Information to Provide to Potential Donors
Cryopreserved embryo donation

In order for consent to donate embryos for research to be
considered informed, the following must be provided:
• Project information: Potential embryo donors should
be informed about the specific research project in
which their embryos will be used. They should be given
a description of the purpose of the proposed project,
including the title of the project, the names of the
principal investigator(s) and the participating
institutions, and the sources of funding. Potential
donors should also be informed that there may be
other possible future research uses that are unknown at
the time.
• Information about voluntary choice: Potential donors
must be informed that their decision is voluntary and
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•

•

•

•

•

that, should they choose not to participate their choice
will be respected. In addition, potential donors must be
informed that they may withdraw their consent to
participate even after they have signed the consent
form. It must be made clear in the consent form what
steps must be taken to withdraw consent. Potential
donors must be informed that if they decide not to
participate, or if they initially consent but later decide
to withdraw from participation, their medical care will
not be affected in any way.
Information about what will be done with donated
embryos: Potential donors must be informed about
what will be done with and to the embryos donated to
research (and with any cell lines, tissue, etc. extracted or
derived from the embryo). If embryos will be destroyed
in the research process, this must be explained to
potential donors. Potential donors must also be
informed that embryos used in research will not be
transferred to a woman’s uterus, nor will they be used
to create a pregnancy.
Risks and benefits of participation in research:
Potential donors must be informed of all of the risks of
embryo donation including the following. They must
be told that donating embryos prior to the completion
of their reproductive goals will reduce the number of
embryos available for reproductive purposes and that,
should they later decide that they wish to undertake
another attempt at conception, women who have
donated embryos for use in research may have to
undergo another egg retrieval cycle, with all of the risks
that this entails. Potential donors must also be
informed about the possible psychological implications
of embryo donation.
Protection of donor’s privacy: Potential donors must
be informed about how their personal information will
be protected in the context of the study, as well as
about any risks to their privacy. In particular, as genetic
information about the donor may be obtained,
potential donors should be told about the risks of
inadvertent disclosure of such information.
Disclosure of researcher’s financial incentives: All the
potential benefits to the researcher and the clinicians
involved in the patient’s care must be disclosed to the
potential donor. This disclosure must include the
possible financial or commercial benefit that may be
derived from the use of the embryo or cells derived
from it, and an explanation that research subjects will
not benefit from commercialization of the products of
the research.
Information about stem cell research: The CIHR
Guidelines stipulate that those donating embryos to
stem cell research must, in addition to the information

usually conveyed to research participants, also be given,
at a minimum, the following information: (1) that the
cell lines will be anonymized; (2) that subjects are free
not to participate, and that they may withdraw their
consent at any time prior to the creation of an
anonymized cell line; (3) that the research could result
in the production of a stem cell line that could be
maintained for many years, distributed to other parts of
the world, and used for various research purposes; and
(4) that subjects will not benefit personally from the
cell lines created, that subjects will not have
dispositional authority over the cell line(s), and that
they will not benefit from any commercialization of the
stem cell line(s).
The above-noted information is necessary but not sufficient for donors’ consent to be fully informed. The CIHR
Guidelines clearly assume that potential donors will be
informed about the risks and benefits of participation in
stem cell research, but it is important to specify in detail
what potential donors should be told in the context of the
informed consent process. Potential donors should also be
informed that stem cell research results in the destruction of
the embryo and that stem cell lines might exist indefinitely
(not just for many years, as outlined in the CIHR Guidelines). Potential donors should also be made aware of
whether true anonymization of stem cell lines is possible.
For example, if stem cell lines are to be used clinically, it will
probably be necessary to re-contact donors to determine
their current health status. Thus, cell lines intended for clinical use cannot be made truly anonymous, and this has implications for the confidentiality of donor health and genetic
information.
Fresh embryo donation

In addition to being given the information required for
donation of cryopreserved embryos set out above, potential
donors of fresh embryos must be informed that a decision
to donate fresh embryos may result in the potential physical,
emotional, and financial harm of further medical and surgical procedures should a woman/couple later decide that
they require additional embryos for reproductive purposes.
Although considerations are similar when a final decision is
made about cryopreserved embryo donation, decisions
about fresh embryos must be made within hours or two
days at most, whereas for cryopreserved embryos, the final
decision can be made after as many years as it takes to come
to this decision. Further, in the case of fresh embryos,
potential donors must make a decision about donation
without knowing the reproductive outcome of the current
IVF cycle.
SEPTEMBER JOGC SEPTEMBRE 2008 l
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Who Should Obtain Consent?

SUMMARY

Crypreserved embryo donation

These guidelines are primarily concerned with safeguarding
the health, well-being, and autonomy of women and couples. Decisions about donation of embryos to research
should be made in accordance with national guidelines2,3
and laws1 that inform the ethical conduct of research
involving human embryos. Safeguards must be present to
ensure that embryos donated for research are no longer
required for reproductive purposes. Obtaining free and
informed consent to the donation of embryos for research
is a multi-staged process. While all persons are affected by
assisted reproductive technologies, women are more
directly and significantly affected than men by their application, and the health and well-being of women are of paramount concern (AHR Act, Section 2).1

The CIHR Guidelines state that “[m]embers of the health
team treating and/or counselling the client should not be
the persons to obtain consent from the embryo provider at
the time of re-consent,” nor should physicians who are part
of the stem cell research team.3 The concerns are physician
conflict of interest and that patients might feel they should
agree to donate embryos to research because their physician, whom they trust, is raising the possibility with
them.4,10,12,17,18 This rule has recently been challenged by
Caulfield et al.,19 on the basis that physicians obtaining consent for donation of embryos for stem cell research is not
different from physicians obtaining consent for other areas
of research participation.
The most important clinical discussion occurs when
embryo cryopreservation is considered, and this discussion
must include a physician intimately involved in the care of
the woman/couple. When a woman/couple indicate to the
clinical team that they no longer require their cryopreserved
embryos for reproductive purposes, the team should determine whether the woman/couple indicated an interest in
donating embryos to research at the time of embryo cryopreservation. If this is the case, a representative of the clinical team who has not been a part of the patient’s care may
contact the woman/couple to inquire whether they are still
interested in donating embryos no longer required for
reproductive purposes to research.11 If the woman/couple
indicate that they are still interested in donating embryos to
research, they should be informed that they will be sent a
package with the details of the specific research study and
will be provided with the information they need to provide
free and informed consent for that research study.
Fresh embryo donation

Separating the clinicians providing patient care from the
free and informed consent process is more problematic for
fresh embryo donation, as the decision not to cryopreserve
all embryos is made following consultation between the
physician responsible and the patient(s). However, once the
decision not to cryopreserve embryos is made, and the irrevocable nature of this decision has been fully explained to
the patient(s), the patient’s name can be given to a clinical
team member who has not participated in, and will not in
the future participate in, the patient’s care in order to
approach the patient about the opportunity to donate their
fresh embryo(s) to a research project.
Withdrawing Consent

The CIHR Guidelines and AHR Act provide that embryo
donors may withdraw their consent at any time prior to the
thawing of frozen embryos or, in the case of stem cell
research, the creation of a stem cell line.
828
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Recommendations
1. As indicated in the Canadian Institutes of Health
Research Guidelines and the Assisted Human Reproduction Act, specific consent from both the gamete and
embryo providers is required before embryos can be
used for research purposes. The gamete donors may be
different individuals than the embryo providers when
donated gametes are used to create embryos.
2. The consent process should inform potential donors of
the possible types of (and for final consent, the specific)
research project(s) for which the embryos will be used;
the risks involved in donating embryos to research, such
as not having these embryos available for their reproductive purposes; the fact that the woman/couple will not
benefit personally from donating embryos to research;
the potential for commercial gain by others; the possibility that they will be contacted in future about the disposition of the embryos; the fact that confidentiality cannot
be absolutely guaranteed.
3. Designation of cryopreserved embryos no longer be
required for reproductive purposes to be donated to
research, donated to another couple, or discarded should
be discussed prior to gamete retrieval and made at the
time of cryopreservation, with the understanding that in
the future, final consent will be requested. The final decision as to the donation of cryopreserved embryos
research should not be made until after the
woman/couple decide they no longer require the
embryos for their reproductive purposes. The decision
to end cryopreservation should be made separately from
the decision regarding disposition of the embryos. The
woman/couple will have to be re-contacted regarding
the final disposition of their embryos.
4. As a result of lack of scientific data regarding the predictability of microscopic characterization of embryos and
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potential for pregnancy,12,20 it is recommended that all
women/couples be offered the opportunity to
cryopreserve all embryos not transferred during the
treatment cycle and be informed that a failure to
cryopreserve all embryos may increase the chance of
having to undergo an additional in vitro fertilization
cycle to achieve reproductive goals.
5. Research participants should be informed that they may
withdraw their consent at any time before the embryos
are thawed for research purposes, or, in the case of stem
cell research, before a stem cell line is created.
6. Potential donors should be informed that their medical
care will not be affected by their decision regarding
embryo donation.
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